J. Heliste

Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia

I. Paatero, K. Elenius, Katri Vaparanta, 2021, Scientific Reports.

Genetic and functional implications of an exonic TRIM55 variant in heart failure.

T. Aittokallio, T. Salminen, J. Paavola, 2019, Journal of molecular and cellular cardiology.

STAT5b is a key effector of NRG‐1/ERBB4‐mediated myocardial growth

K. Alitalo, P. Taimen, I. Paatero, 2023, EMBO reports.

Pharmacogenomic profile of a central European urban random population-Czech population

M. Vinciguerra, Š. Kunzová, J. González-Rivas, 2023, PloS one.

Effectiveness of non-medical health worker-led counselling on psychological distress: a randomized controlled trial in rural Nepal

V. Lehti, N. Markkula, B. Guragain, 2019, Global Mental Health.

Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target

I. Paatero, T. Savunen, M. Laaksonen, 2018, BMC Cardiovascular Disorders.

STAT5b is a key effector of NRG-1/ERBB4-mediated cardiomyocyte 1 growth 2 Short title: STAT5b in NRG-1 mediated cardiac growth

P. Taimen, I. Paatero, K. Elenius, 2022 .